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Background: With the rapid advancement of cell biology, the evaluation of a given protein’s synthesis and release
in cells becomes critical. However, up to now there has been no technique available to morphologically visualize
and measure a newly synthesized protein in cells, nor can we measure the protein’s release from the cells.
Results: In this study, we developed a set of assays combining pulse chase amino acid substitution, non-radioactive
labeling, and immunofluorescence co-localization to visualize newly synthesized proteins in individual cells and then
to detect their release using modified ELISA. We demonstrated the synthesis and release of Bcl-2, MMP-9, and
immunoglobulin G (IgG) in a human trophoblast cell line, of which the last finding has not been reported previously.
Conclusions: This new technique offers a powerful tool to evaluate the dynamics of the synthesis and release of target
proteins in individual cultured cells with wide applications in genetic and protein analysis.
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There are on average about 10,000 proteins per cell with
about one million copies each [1]. The dynamics of pro-
tein synthesis and release constitutes a major part of the
biological activities that maintain the structure and func-
tion of a cell. Many techniques are available to detect pro-
teins within cells, however, there has been no technique
dedicated to dynamically monitor and visualize the syn-
thesis and release of a particular protein or its peptides in
individual cells. Immunohistochemistry with a wealth of
specific antibodies can visualize a particular protein or
peptides in its static presence in cells, but cannot yield
data about the synthetic activities or follow the process of
protein or peptide synthesis and release. Pulse chase assay,
which incorporates radioisotope-labeled amino acid sub-
stitutes in newly synthesized proteins, can detect newly
synthesized proteins in their entirety but not measure the* Correspondence: 2523381625@qq.com
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unless otherwise stated.synthesis of a particular protein/peptide. Nor can it
visualize the newly synthesized proteins in cells morpho-
logically. With increased importance of detecting genomic
alternations and subsequent changes in protein synthesis,
as a base for molecular and personalized medicine, and
the recent discovery of a large number of gene switches,
there is a surge of demand for measuring the dynamics of
synthesis of a particular protein and then detecting its
release in individual cells, but a reliable technique to
address this need has not been available.
Recently, small bioorthogonal functional groups, espe-
cially L-homopropargylglycine (HPG) with alkyne group
or L-azidohomoalanine (AHA) with azid group, a surro-
gate for L-methionine, have been adopted to tag proteins
[2], glycans [3] and lipids [4] in cells. After giving HPG or
AHA to cultured cells, the tags are incorporated into
newly synthesized proteins that can be extracted from the
cells. The alkyne-labeled or azide-labeled proteins can be
covalently coupled to azide-biotin or alkyne-biotin that
can be detected with western blot. The newly synthesizedLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ential 2D electrophoresis and mass spectrometry (MS)
[2,5]. This technique offers the possibility of measuring
particular protein synthesis but the protocol is cumber-
some, labor-intensive, and expensive, and the derived data
are complicated and often confusing due to the large
number of new proteins synthesized in any given cell at
any given time. Although there are reports that newly syn-
thesized total proteins can be visualized morphologically
after non-radioactive labeling with a pulse chase assay [2],
there is no report about the synthesis of particular pro-
teins of interest in cells morphologically.
We developed a new technique combining non-
radioisotope labeling of amino acid substitute, pulse chase
assay, azide-Alex555 or azide-biotin labeling reaction, im-
munofluorescence co-localization, and image analysis that
can visualize the synthesis of any particular protein mor-
phologically in cultured cells, and then detect its release
semi-quantitatively with ELISA. We used a human placen-
tal trophoblast cell line (TEV-1) as a model and demon-
strated the synthesis and release of three proteins Bcl-2,
MMP-9, and IgG, of which the last finding has not been
reported previously. The reliability and reproducibility of
this technique were verified with extensive controls in-
cluding down-regulation of the above three target proteins
with inhibition of their mRNA expressions with siRNA
post-transfection. By varying the timing and duration of
labeled amino acid incorporation, the dynamic changes of
a particular protein synthesis and release can be traced to
evaluate their activities.
Results
The results of the technique provide images of a number
of activities within the positive cells of interest. The newly
synthesized protein of interest was demonstrated with a
distinct color labeling resulting from the overlapping of
two colors, one delineating total proteins of interest and
another displaying total newly synthesized proteins. The
co-localization of the two color images gives rise to a third
color demonstrating the amount and location of the newly
synthesized protein of interest. The total portion of the
particular protein of interest was provided by the results
of immunoflourence staining with specific antibodies. The
positive staining would represent both previously synthe-
sized and newly synthesized portion of this protein. The
total newly synthesized protein was demonstrated by the
Alex555 labeling derived from the newly incorporated
amino acid substitute during the synthesis of new proteins
in the cells. The positive signals of this reaction would
represent the total proteins of all kinds. The overlapping
portion as demonstrated by the collaboration of the two
distinct fluorescent colors, green for total existence of the
protein of interest and red for the total newly synthesized
protein, gave rise to a third color, in this case white, thatdemonstrated the newly synthesized protein of interest.
The overlapping portion can be calculated by measuring
the portions of the two fluorescent color co-localization of
the morphological image with an image analyzing soft-
ware. The controls of the technique were provided by the
routine controls for immunofluorescence staining and
pulse chase assay and a siRNA inhibition technique to
specifically decrease the synthesis of the particular protein
of interest, as described in the following section. The
release of the newly synthesized proteins was measured
with modified ELISA by detecting their concentration
in the supernatant. The dynamics of their release was
demonstrated.
General description of the technique
The technique consists of seven steps. 1. Administration
of labeled amino acid substitute, HPG or AHA, into cul-
tured cells seeded on slides with culture medium deprived
of the replaced amino acid, in this case L-methionine.
2. After a pre-determined duration, label the incorporated
amino acid substitute with Alex555 (red florescence) for
immunofluorescence of newly synthesized proteins in cells
or with biotin for the detection of their release into the
supernatant. 3. Detect the Alex555 labeling with immuno-
florescence to visualize the total newly synthesized proteins
on the glass slide with a confocal microscope. 4. Detect
the particular proteins of interest with specific antibodies
and immunoflorescent staining with a different color
(Alex448, green florescence). 5. Generate double labeling
image with a confocal microscope and identify co-
localization of the particular proteins of interest and the
total newly synthesized proteins with an image analyzing
software, and then calculate the percentage of the newly
synthesized target proteins in individual cells. 6. Varify
the specificity of immunofluorescence co-localization with
siRNA interference assay combined with morphological
visualization to show that the newly synthesized target
proteins were declined in quantity when their mRNAs
were inhibited by the specially designed RNAi for the
particular proteins. 7. Detect the newly synthesized target
proteins in the supernatant captured by primary antibody
coated on the wells followed by biotin label with a
modified ELISA analysis and describe the dynamics of
their release.
Newly synthesized proteins, including total proteins,
Bcl-2, MMP-9, and IgG, detected in cultured cells with
western blot
To establish the technique, we first determined the syn-
thesis of total proteins, Bcl-2, MMP-9, and IgG in cell ex-
tracts with non-radioactive labeling of pulse-chase assay.
The principle of HPG metabolic incorporation and label-
ing reaction is shown in the Figure 1A [6]. Briefly, HPG
incubation in DMEM free of L-methionine lasted for 4 hr
Figure 1 Schematic diagram showed non-radioactive metabolic incorporation followed by azide-biotin or azide-Alex555 labeling, and
biotin signals of proteins were detected by streptavidin-HRP by western blot. HPG is incorporated into newly synthesized proteins by
metabolism and protein synthesis and the triazole conjugation between newly alkyne proteins labeled HPG and azide labeled either biotin or
Alex555 via CuSO4 catalysis (A). (B-a) The detection of biotin signals from extracted total proteins labeled by labeling reaction. Normal culture
medium was changed to replace DMEM free of L-methionine supplemented with HPG after pulse 4 hr, and proteins were extracted in each of group
at various time points including 0, 4, 24 and 72 hr. (B-b) Biotin signals of total proteins were detected. 1: Normal culture condition group; 2: HPG plus
anisomycin group; 3: HPG group. (B-c,d,e) Biotin signals of Bcl-2, MMP-9 and IgG were individually detected in the immunoprecipitate pulled down by
primary antibodies via siRNA post-transfection followed by non-radioactive metabolic labeling. (B-f) Radioactive isotope 35S-methonine incorporated
into synthesized IgG purified by immunoprecipitation was detected by autoradiography. 1: 35S-methonine treated human choriocarcinoma cell
line BeWo group and then antibody against human IgG immunoprecipitated human IgG in extracted total proteins; 2: cycloheximide
plus 35S-methonine treated BeWo group then antibody against human IgG immunoprecipitated human IgG in extracted total proteins; 3: 35S-methonine
treated skin fibroblast and then antibody against human IgG immunoprecipitated human IgG in extracted total proteins.
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tein was extracted and labeled with azide-biotin in a
CuSO4 catalystic reaction between azide from azide-biotin
and alkyne from HPG. Biotin signals were detected with
streptavidin-HRP with western blot. If the biotin signalsfrom newly synthesized proteins were detected, the evi-
dence of new protein synthesis in cells was obtained. The
results of our experiment showed that HPG was success-
fully incorporated into newly synthesized proteins and
Bcl-2, MMP-9, and IgG were synthesized in TEV-1 cells
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synthesized IgG was further proved by radioactive pulse
chase (Additional file 1, Figure 1B-e) and IgG mRNA
transcription was also further demonstrated by RT-PCR
(Additional file 1: Figure S1).Figure 2 The transcripts of target gene Bcl-2 and IgG post-siRNA tran
analysis of Alex488 and Alex555 was performed. (A) The transcripts of
in TEV-1 cells by real time RT-PCR. (B) Immunofluorescence signals for Alex
546 nm emition wavelength in HPG and HPG plus anisomycin treated grou
co-localization analysis of Alex488 (green) and Alex555 (red). White dots, as ar
Bcl-2 and IgG proteins, respectively. (D) The percentage of immunofluorescen
Bar: 5 μm; Magnification: 10 ×100. Data are presented as means ± S.E. of threeBcl-2 and IgG mRNA levels in cultured cells detected with
real time RT-PCR post-siRNA transfection
To acquire effective siRNA oligos to be used for testing
the specificity of immunofluorescence co-localization,
mRNA levels of the two genes were measured with realsfection were detected and immunofuorescent co-localization
target gene Bcl-2 and IgG post-siRNA transfection 48 hr were detected
555 (red) were observed with a Zeiss laser confocal microscope at
p. Nuclear staining was performed with DAPI. (C) Immunofuorescent
rows were shown in big magnification, represented newly synthesized
ce co-localization of Alex488 and Alex555 in TEV-1 cells was detected.
independent experiments (*P < 0.05; **p < 0.01).
Table 1 The results of statistical analysis for
immunofluorescence co-localization
Scramble siRNA Bcl-2 siRNA Scramble siRNA IgG siRNA
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fective siRNA oligos were acquired. The details were
described in Additional file 1.AVE 2.161 0.677 0.386 0.033
SE 0.366 0.341 0.143 0.027
P 0.002 0.04
AVE: Average of the percentage of immunofluorescence co-localization;
SE: standard errors.Immunofluorescence staining to detect total protein
synthesis in situ morphologically
HPG was incorporated into newly synthesized proteins
and subsequently labeled with azide-Alex555. Immuno-
fluorescence signals were observed with a Zeiss laser con-
focal microscope at 546 nm emittion wavelength. The
results showed the total newly synthesized proteins in the
cytoplasma and the nucleus (Figure 2B, Alex555 group).
To establish the specificity of immunofluorescence stain-
ing, a HPG protein synthesis inhibitor, anisomycin, was
added to culture medium and the immunoinfluorescnt
signals were completely abolished (Figure 2B, Anisomycin
group).Table 2 OD value of serial diluted IgG-biotin standard
detected by ELISA
OD value 0.083 0.1215 0.2569 0.7856 2.1300 3.8900
Concentration (ng/ml) 0 14 28 56 112 224
Serial diluted IgG-biotin conjugate was incubated with streptavidine-HRP and
OD value was detected after 3, 3′, 5, 5′tetramethylbenzidine color development
and 2 M H4SO4 termination reaction. n = triplicate.Immunofluorescen co-localization analysis to detect
target protein synthesis in situ morphologically
On the same preparation of cytospin slides used for
detecting total newly synthesized proteins described
above, we respectively detected the two target proteins
(Bcl-2 and IgG) with immunofluorescence (Alex488,
green florescence) with primary antibodies and second-
ary antibody (goat anti-mouse IgG-Alex488) and IgG
was directly detected with mouse anti-human IgG-
Alex488 diluted with labeling reaction buffer. Immunore-
activities of the two proteins were readily demonstrated in
the cytoplasm or nuclear of the cell line. On the slide
preparation, three overlapping photographs were ob-
tained, i.e. red florescence to demonstrate the total newly
synthesized protein, green florescence to demonstrate the
existence of the particular protein of interest, and the
white florescence derived from the collaboration of the
red and the green color to display the location and
quantity of the newly synthesized protein of interest
(Figure 2C). After siRNA transfection, the positive
fluorescent signals were markedly declined in compari-
son to the scramble control (Figure 2C). We calculated
the percentage of white pixels, representing Alex488
and Alex555 co-localization, against the total pixel area
of the cytoplasm of each cell. The percentage of white
pixels of the siRNA treated cells was compared to that
of the scrambled control group where no inhibition of
protein synthesis was induced. The percentage of im-
munofluorescence co-localization of Alex555 and Alex488
for Bcl-2 was reduced by 3.2-fold in the siRNA group in
comparison to the Bcl-2 scramble group, and the percent-
age of immunofluorescence co-localization of IgG was re-
duced by 11.7-fold in comparison to the control group
(Figure 2D; Table 1).Newly synthesized target proteins released from cultured
cells
Combined with diluted IgG-biotin conjugate, we mea-
sured serial OD values in response to serially diluted
IgG-biotin conjugate with Streptavidine-HRP with a
modified ELISA method. The IgG-biotin conjugate was
diluted to 224 ng/ml, 112 ng/ml, 56 ng/ml, 28 ng/ml,
14 ng/ml, 0 ng/ml (Table 2). We detected the release of
IgG in TEV-1 cell culture supernatant and demon-
strated that there was newly synthesized IgG in culture
supernatant by a modified ELISA (Figure 3A). Newly
synthesized IgG release was prevented by addition of
HPG plus anisomycin. The OD value of negative con-
trols, which included normal culture medium and PBS,
was the same to the background OD value (Table 3).
Alternatively, we measured IgG secretion in TEV-1 cell
culture supernatant with a commercial human IgG
ELISA kit (Immunology Consultants Laboratory, Oregon,
USA) and IgG release in supernatant was undetectable.
Therefore, our method of detection for newly synthesized
target protein release was more sensitive than the com-
mercially available ELISA kit.
Likewise, newly synthesized MMP-9 protein with HPG
was also secreted into culture supernatant and captured
with mouse anti human MMP-9 coated on the wells and
labeled with azide-biotin. The biotin labeled MMP-9 was
incubated with streptavidine-HRP and biotin signals of
MMP-9 were detected with an adapted ELISA. Com-
bined with serially diluted MMP-9 labeled with biotin,
the results showed that the OD value of MMP-9 protein
from supernatant of HPG group was over the back-
ground level and the OD value of supernatant from
HPG plus inhibitor, culture medium and PBS group was
lower than the background OD value, indicating that
TEV-1 cell line secreted newly synthesized MMP-9 pro-
tein (Table 4). The release of newly synthesized MMP-9
was also preventable by adding anisomycin (Table 5).
Figure 3 Newly synthesized protein secretion was detected. (A) The schematic diagram illustrated the detection of newly synthesized protein
release in the culture supernatant. Newly synthesized proteins from HPG group were labeled with azide-biotin in situ, by clicking its reaction, the biotin
signals were incubated with streptavidine and measured by an ELISA reader. (B) The dynamic curve for newly synthesized MMP-9 proteins was set up
corresponding to various time points by adapted ELISA method. Normal culture condition was treated as negative control and selected as baseline
and named as pulse 0; chase 0. Pulse 1 h, chase 0 h named as pulse 1; chase 0. Pulse 4 h, chase 0 h named as pulse 4; chase 0. Pulse 4 h, chase 0.5 h
named as pulse 4; chase 0.5. Pulse 4 h, chase 2 h named as pulse 4; chase 2. Pulse 4 h, chase 4 h named as pulse 4; chase 4. Pulse 4 h, chase 24 h
named as pulse 4; chase 24. (C) The dynamics curve for newly synthesized IgG protein was set up corresponding to various time points. Normal culture
condition was treated as negative control and selected as baseline, and the named method for various time points was similar to MMP-9.
Table 3 OD value of secreted IgG detected by ELISA in cell culture supernatant
Normal culture condition HPG HPG plus anisomycin Normal culture medium PBS
OD value 0.078 0.1473 0.0799 0.0800 0.0820
Newly synthesized IgG in culture supernatant was detected by non-radioactive metabolic method combined with an adapted ELISA method. Triplicate for each
sample. n = triplicate.
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Table 4 OD value of serial diluted MMP-9-biotin standard
detected by ELISA
OD value 0.0800 0.2700 0.4700 0.7400 1.3600 2.1900
Concentration (ng/ml) 0 10 20 40 80 160
Serial diluted MMP-9-biotin conjugate was incubated with streptavidine-HRP and
OD value was detected after 3, 3′, 5, 5′tetramethylbenzidine color development
and 2 M H4SO4 termination reaction. n = triplicate.
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release, we calculated the changes in OD values of HPG
treated and untreated samples according to the equation
for “fold change = A/N” (“A” is OD value of the testing
sample and “N” is OD value of the untreated negative
control). The change of dynamics was illustrated with a
curve with X-axis representing various time points and
Y-asix representing changes in quantity. On evaluating
the dynamics of newly synthesized MMP-9 release, we
found that it was increased from 1 h to 4 h following
adding HPG to DMEM free of L-methionine and in-
creased from 0.5 h to 2 h following adding normal cul-
ture media. In the HPG group, its release was gradually
declined from 4 h to 24 h (Figure 3B). We also detected
the dynamics of IgG release which was similar to that of
MMP-9 (Figure 3C).
Statistical analysis
Statistical analysis was described in Additional file 1.
Discussion
To examine the expression profile of target proteins of
interest in specific cell type was very important to pro-
vide the direct evidence for target gene expression from
mRNA translation to protein synthesis in a given cell
type. Previously, newly synthesized proteins can only be
visualized in their totality with confocal microscope [7],
and visualization of target proteins of interest in cells
has not been possible. Now, we have established a non-
radioactive method to evaluate target protein synthesis
in intact cells morphologically and measured their release
semi-quantitatively.
Immunohistochemistry and in situ hybridization have
been used extensively to demonstrate the occurrence
and distribution of a particular protein or peptide anti-
gen morphologically. These techniques, however, cannot
distinguish existing molecules from newly synthesized
molecules. In addition, certain proteins and peptides can
be phagocytized into cells or internalized via specific re-
ceptors, such as transpassing of IgG into placentalTable 5 OD value of secreted MMP-9 detected by ELISA in cel
Normal culture condition HPG HP
OD value 0.2977 0.6009 0.2
Newly synthesized MMP-9 in culture supernatant was detected by non-radioactive
sample. n = triplicate.trophoblasts, it is not possible to distinguish locally syn-
thesized proteins from proteins with an extracellular ori-
gin. IgG in trophoblasts would be a good example [8].
Also, the study demonstrated that IgG was expressed in
TEV-1 cells by immunochemistry, in situ hybridization
and immunofluorescence [9]. With the new technique,
we were able to establish that IgG can be synthesized in
placental trophoblasts in addition to being transported
from the maternal blood pool. Details of this discovery
will be published separately.
The specificity of this combined technique has been
established with a number of controls. In addition to the
usual controls for immunostaining, western blotting,
and ELISA, we used siRNA to specifically inhibit the ex-
pression of a target protein of interest. The results
showed unequivocally that the reactions were specific
and reproducible. Therefore, this technique, for the first
time, provides a tool to evaluate the synthesis and re-
lease of a particular protein in intact cells morphologic-
ally and semi-quantitatively.
Conclusions
The ability to morphologically demonstrate the synthesis
of a particular protein in intact cells and then measure
its release provides a powerful tool to investigate many
biological and cellular events that cannot be evaluated
effectively otherwise. The potential applications of this
technique can be summarized into the following aspects.
First, it can determine the synthetic activity of a given
protein in a particular cell type. Apparently the demon-
stration of the presence of the particular protein of
interest in the cells with immunohistochemistry or im-
munofluorescence is not a sufficient evidence for recent
protein synthesis as the proteins can be internalized
from outside of the cells or may have stayed in the cells
for a long time. Currently this can be demonstrated
only by in situ hybridization to show the presence of
relevant mRNA in the cells of interest. Northern blot
and RT-PCR can also detect the mRNA but will not
correlate to tissue and cell morphology. The in situ
hybridization data are also not ideal as they offer no clue
as to how long the mRNA has been presented in the cells
and if it is newly transcribed or left over from old syn-
thetic activities. Pulse chase assay combined with western
blot or ELISA offers definitive proof of local synthesis but
does not generate data concerning the cell types that actu-
ally synthesize the protein. In this regard, the new tech-
nique will provide the answer to the critical question ofl culture supernatant
G plus anisomycin Normal culture medium PBS
429 0.2992 0.0849
metabolic method combined with an adapted ELISA method. Triplicate for each
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detection of IgG production by placental trophoblasts is a
good example of this technical strength. The trophoblast
cells are known to uptake IgG from the adjunct blood
pool of the mother with specific Fc receptors and trans-
port them to the fetus side. The new technique would be
able to demonstrate that the trophoblasts are indeed able
to synthesize IgG themselves in addition to internalizing
IgG from the adjacent maternal blood pool. With this new
technique, the two portions of IgG, i.e. the locally pro-
duced and externally transported, in the same trophoblast
cells can be visualized and distinguished from each other.
This technique also enables investigators to trace the
protein synthesis events chronically so as to demonstrate
the time needed for a particular protein synthesis to begin,
to reach its peak, and to decline. It can also detect if a par-
ticular protein is released from a particular cell type and
at what rate in order to assess its possible functions. It can
also trace this newly synthesized and tagged protein to as-
sess its reactivity with other molecules such as receptors,
antigens, antibodies, enzymes or other factors.
By manipulating gene expression with siRNA, up or
down regulation, the corresponding proteins would change
their expression profile. The new technique would be able
to provide accurate information about the protein synthe-
sis and release dynamically and semi-quantitatively. The
morphological demonstration of a newly synthesized pro-
tein and its release can be examined together or separately
as needed.
As the evaluation of the expression profile of individual
proteins becomes more important in developing personal-
ized medical diagnosis and treatment, the current tech-
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GAPDHF12(Hyclone, Logan, USA) medium. Metabolic labeling
experiment for cells was performed until 80-90% con-
fluence as described [2]. After incubating cells with
DMEM free of L-methionine (Invitrogen, California, USA)
for 30 min at 37°C, 5% CO2, HPG (Invitrogen, California,
USA) at final concentration 50 μM in culture medium,
was added to DMEM free of L-methionine for 4 hr. The
above DMEM with HPG was changed into normal
medium for 4 hr. Normal culture condition was served as
negative control. HPG plus 40 μM anisomycin (Sigma,
Missouri, USA), a protein synthesis inhibitor, were added
to cultured cells as control. HPG was incubated with cul-
tured cells for 4 hr and then changed into normal culture
medium for 0, 4, 24, and 72 hr. Cell proteins were ex-
tracted and labeled by biotin and the newly synthesized
Bcl-2, MMP-9, and IgG were detected by biotin signal
detection and the detailed procedure was described in
Additional file 1.RNAi for Bcl-2, MMP-9, and IgG and the detection of the
three gene mRNA level with real time RT-PCR and newly
synthesized Bcl-2, MMP-9, and IgG proteins detected by
immunoprecipitation
siRNA oligos were designed according to IgG VDJ mRNA
sequence(AY270190.1) in cancer cells on NCBI database
(http://www.ncbi.nlm.nih.gov/) submitted by Qiu [10] and
the sequence of siRNA oligos for Bcl-2 and MMP-9 were
from references [11,12]. All the siRNA oligos were synthe-
sized by GenePharm Company (Shanghai, China).
Cell transfection was performed as the method by Brian
Dalbyb [13]. Each sample was collected post-transfection
and extracted total RNA concentration was detected with
Nanodrop-2000c (Thermo, Massachusetts, USA) and the
procedures of real time RT-PCR were performed. The
sequence of siRNA oligos and the primers for real time
RT-PCR were shown in the following Table 6. The con-
centration of extracted proteins was detected with BCA
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above.
Immunofluorescence double staining for Alex488 and
Alex555
TEV-1 cells were grown on cover slides and non-
radioactive metabolic labeling was performed. Immuno-
fluorescence staining followed by labeling reaction by
azide-Alex555 (Invitrogen, California, USA) was per-
formed. Cells were fixed with 4% Paraformaldehyde in
PBS and perforated by 0.25% Triton X-100 in PBS and
block with normal mouse serum at room temperature
for 1 hr and incubated with mouse anti human Bcl-2 at
4°C overnight and Alex488-goat anti mouse IgG as sec-
ondary antibody (Cell Signal Technology, Boston, USA).
Alex488-mouse anti human IgG (Invitrogen, California,
USA) was directly used to detect IgG protein in cells. In
situ labeling from azdie-Alex555 for each sample was per-
formed according to kit procedure (Invitrogen, California,
USA). Immunofluorescence staining was observed and
taken photos by Zeiss laser confocal microscope with
100× oil lens at 405, 488, and 546 nm emition wavelength.
Immunofluorescence co-localization analysis by Imaris
software and the detection of the specificity for
immunofluorescence co-localizaiton by RNA interference
Immunofluorescence double staining for Alex488 for Bcl-
2 and IgG and Alex555 for newly synthesized proteins was
performed as the method above siRNA post-transfection.
Serial planes as 1 μm thickness were acquired by Zeiss
confocal microscope and the percentage of immunofluor-
escence co-localization of the very median plane was
calculated by Imaris 6.3.1 software (Bitplane, Zurich,
Switzerland). The threshold of two of labels was set to
30% of the highest intensity value for Bcl-2 and IgG to
distinguish them from non-specific staining [14]. RNA
interference technology was used to detect the specifi-
city for immunofluorescence co-localization.
The detection of the release of newly synthesized target
proteins with non-radioactive metabolic labeling
combined with modified ELISA
TEV-1 cells were grown on the twenty-four well plate,
HPG at final concentration 50 μM was added to DMEM
free of L-methionine and incubated for 4 hr and changed
into 500 μl normal culture medium overnight. HPG plus
anisomycin, normal culture condition, normal culture
medium, and PBS were set up as negative control for
ELISA. 500 μl culture supernatant was concentrated and
adjusted into 100 μl volume and MMP-9 was incubated
with mouse anti human coated on the enzyme strips
at room temperature for 1 hr and labeled in situ with
azide-biotin. In situ labeling from azdie-biotin for
each sample was modified according to kit procedure(Invitrogen, California, USA). Briefly, 500 μl volume per
labeling reaction was composed of 440 μl reaction buffer,
10 μl CuSO4, 50 μl reaction additive and azide-biotin at
final concentration 5 μM and labeling reaction and final
100 μl labeling reaction solution was added to each well
and incubated at room temperature for 30 min. The biotin
signals of MMP-9 were detected with streptavidin-HRP
(Thermo, Massachusetts, USA) and OD value for each
sample was detected by modified ELISA. Commercial
MMP-9 standard or IgG standard (Biosythesis biotechnol-
ogy, Beijing, China) was labeled with biotin according to
the procedure of AnaTag™ biotin microscale protein label-
ing kit (AnaSpec, California, USA). Briefly, 1 mg standard
was mixed with 1/10 volume reaction buffer and incu-
bated with biotin-X SE in DMSO at room temperature for
30 min and the biotin-protein conjugates diluted in PBS
was purified with desalting column and the eluent was
concentrated and adjusted to 100 μl volume and the con-
centration of standards was detected and diluted into
several serial concentrations. Each diluted standard was
incubated with primary antibody coated on the well and
streptavidin-HRP and OD value for each sample was de-
tected by ELISA. To explore the dynamics of the release
of newly synthesized proteins, supernatant in cultured
cells was collected at various time points from 0-24 hr
after HPG incorporated into proteins, and OD value for
newly synthesized target proteins in collected supernatant
was detected by modified ELISA above.Statistical analysis
Statistical analysis was performed for the results of real
time RT-PCR for target gene message RNA level pre-
transfection and post-transfection and the percentage
of immunofluorescence co-localization of Alex488 and
Alex555 using t-test by Excel software with significance
set at 0.05. In analysis where siRNA and scramble groups
were compared, analysis of variance was performed.Additional file
Additional file 1: Supplement methods and results.Abbreviations
IgG: Immunoglobulin G; HPG: L-homopropargylglycine; AHA: L-azidohomoalanine.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
GH Performed most of experiments and data analysis; YW and JW Participated
in the experimental design, result evaluation, and the manuscript editing; CY
Carried out autoradiography test; TH Complement western blot; ZZ Designed
autoradiography test and analyzed its data; JG Conceived and directed all
experiments, and wrote and edited the manuscript. All authors read and
approved the final manuscript.
Huang et al. BMC Cell Biology 2014, 15:45 Page 10 of 10
http://www.biomedcentral.com/1471-2121/15/45Acknowledgements
This work was supported by grants from the National Natural Science
Foundation of China (81001199 to Z.C., 30971150 to J.G.).
Author details
1Department of Pathology and Pathophysiology, Guangdong Provincial Key
Laboratory of Infectious Disease and Immunopathology, Shantou University
Medical College, Shantou, Guangdong 515041, China. 2Surgical Neurology
Branch, National Institute of Neurological Disorders and Stroke, National
Institutes of health, Bethesda, Maryland 20892, USA.
Received: 15 July 2014 Accepted: 25 November 2014
References
1. Vuong GL, Weiss SM, Kammer W, Priemer M, Vingron M, Nordheim A, Cahill MA:
Improved sensitivity proteomics by postharvest alkylation and radioactive
labeling of proteins. Electrophoresis 2000, 21:2594–2605.
2. Dieterich DC, Link AJ, Graumann J, Tirrell DA, Schuman EM: Selective
identification of newly synthesized proteins in mammalian cells using
bioorthogonal noncanonical amino acid tagging (BONCAT). Proc Natl Acad
Sci 2006, 25:9482–9487.
3. Luchansky SJ, Goon S, Bertozzi CR: Expanding the diversity of unnatural
cell surface sialic acids. Chembiochem 2004, 3:371–374.
4. Jao CY, Roth M, Welti R, Salic A: Metabolic labeling and direct imaging of
choline phospholipids in vivo. Proc Natl Acad Sci 2009, 36:15332–15337.
5. Wang Q, Chan TR, Hilgraf R, Fokin VV, Sharpless KB, Finn MG: Bioconjugation
by copper (I)-catalyzed azide-alkyne [3 + 2] cycloaddition. J Am Chem Soc
2003, 11:3192–3193.
6. Beatty KE, Liu JC, Xie F, Dieterich DC, Schuman EM, Wang Q, Tirrell DA:
Fluorescence visualization of newly synthesized proteins in mammalian
cells. Angew Chem Int Ed Engl 2006, 44:7364–7367.
7. Dieterich DC, Hodas JJ, Gouzer G, Shadrin IY, Ngo JT, Triller A, Tirrell DA,
Schuman EM: In situ visualization and dynamics of newly synthesized
proteins in rat hippocampal neurons. Nat Neurosci 2010, 7:897–905.
8. Ben-Hur H, Gurevich P, Elhayany A, Avinoach I, Schneider DF, Zusman I:
Transport of maternal immunoglobulins through the human placental
barrier in normal pregnancy and during inflammation. Int J Mol Med 2005,
3:401–407.
9. Yang M, Ha C, Liu D, Xu Y, Ma Y, Liu Y, Nian Y: IgG expression in trophoblasts
derived from placenta and gestational trophoblastic disease and its role in
regulating invasion. Immunol Res 2014, 60:91–104. Epub ahead of print.
10. Zheng J, Huang J, Mao Y, Liu S, Sun X, Zhu X, Ma T, Zhang L, Ji J, Zhang Y,
Yin CC, Qiu X: Immunoglobulin gene transcripts have distinct VHDJH
recombination characteristics in human epithelial cancer cells. J Biol Chem
2009, 20:13610–13619.
11. Novo E, Marra F, Zamara E, Valfrè di Bonzo L, Monitillo L, Cannito S, Petrai I,
Mazzocca A, Bonacchi A, De Franco RS, Colombatto S, Autelli R, Pinzani M,
Parola M: Overexpression of Bcl-2 by activated human hepatic stellate
cells: resistance to apoptosis as a mechanism of progressive hepatic
fibrogenesis in humans. Gut 2006, 8:1174–1182.
12. Brule S, Charnaux N, Sutton A, Ledoux D, Chaigneau T, Saffar L, Gattegno L:
The shedding of syndecan-4 and syndecan-1 from HeLa cells and human
primary macrophages is accelerated by SDF-1/CXCL12 and mediated by
the matrix metalloproteinase-9. Glycobiology 2006, 6:488–501.
13. Dalby B, Cates S, Harris A, Ohki EC, Tilkins ML, Price PJ, Ciccarone VC:
Advanced transfection with Lipofectamine 2000 reagent: primary neurons,
siRNA, and high-throughput applications. Methods 2004, 33:95–103.
14. Studler B, Sidler C, Fritschy JM: Differential regulation of GABA (A) receptor
and gephyrin postsynaptic clustering in immature hippocampal neuronal
cultures. J Comp Neurol 2005, 484:344–355.
doi:10.1186/s12860-014-0045-1
Cite this article as: Huang et al.: A morphologic and semi-quantitative
technique to analyze synthesis and release of specific proteins in cells.
BMC Cell Biology 2014 15:45.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
